Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 540752-87-2 | MDL No. : | MFCD07781212 |
Formula : | C21H33BN2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RJUYJGNYCCEDAH-UHFFFAOYSA-N |
M.W : | 388.31 | Pubchem ID : | 16414220 |
Synonyms : |
|
Num. heavy atoms : | 28 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 120.12 |
TPSA : | 51.24 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.05 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.69 |
Log Po/w (WLOGP) : | 2.28 |
Log Po/w (MLOGP) : | 1.97 |
Log Po/w (SILICOS-IT) : | 1.72 |
Consensus Log Po/w : | 1.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.4 |
Solubility : | 0.0154 mg/ml ; 0.0000397 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.46 |
Solubility : | 0.0136 mg/ml ; 0.000035 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.61 |
Solubility : | 0.00955 mg/ml ; 0.0000246 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.75 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
[10] Tert-butyl 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine-1-carboxylate was used as a reagent and after coupling, the Boc group was removed with trifluoroacetic acid in DCM. The resultant product gave the following characterising data: Mass Spectrum: M+H+ 372.11; RT 2.41 min; NMR Spectrum: (DMSOd6) 8.56 (1H, d), 8.47 (1H, d), 7.79-7.88 (2H, m), 7.76 (2H, s), 7.41-7.50 (2H, m), 7.31 (1H, t), 7.18 (1H, s), 7.07 (1H, d), 6.92 (1H, dd), 3.15 (4H, t), 2.87 (4H, t). The tert-butyl 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine-1-carboxylate used as a reagent was prepared as follows: | ||
With 1,1'-bis-(diphenylphosphino)ferrocene; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate; In 1,4-dioxane; at 80℃; for 4h; | General procedure: An oven dried resealable Schlenk tube was charged with tert-butyl [2-(3-bromophenyl)ethyl]carbamate (preparation 3a, 0.29 g, 0.96 mmol), bis(pinacolato)diboron (0.27 g, 1.05 mmol), potassium acetate (0.28 g, 2.88 mmol) and dioxane (4 mL). The Schlenk tube was subjected to three cycles of evacuation-backfilling with argon, and 1,1'-bis(diphenylphosphino)ferrocene-palladium(II) dichloride dichloromethane complex (0.02 g, 0.03 mmol) and 1,1'-bis(diphenylphosphino)ferrocene (0.02 g, 0.03 mmol) were added. After three further cycles of evacuation-backfilling with argon, the Schlenk tube was capped and placed in an oil bath at 80 C. After 4h, the mixture was cooled and ethyl acetate and satured aqueous trimethylammonium chloride solution was added. The organic layer was washed with satured aqueous trimethylammonium chloride solution, dried (MgSO4) and evaporated to give the desired compound in quantitative yield. The crude material was used without further purification.LRMS (m/z): 264 (M-1)-. | |
General procedure: Step-ii: 1-(2-fluorobenzyl)-4-( 4,4,5 ,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1 H-pyrazole1-(2-fluorobenzyl)-4-iodo-1H-pyrazole (2.25 g, 7.4 mmol) and bispinocalatodiboron (2.07 g,8.2 mmol) were added to a solution of DMSO (20 ml) previously purged with argon (10min). The reaction mixture was purged with argon for a further 15mins, followed by the10 addition of potassium acetate (2.19 g, 22.3 mmol) andbis(triphenylphosphine)palladium(II)dichloride (261 mg, 0.3725 mmol). The resultingmixture was heated to reflux at 80 oc overnight. The reaction was monitored by TLC (40%ethyl acetate in hexane). The reaction mixture was cooled and diluted with ethyl acetate (100ml) and filtered over celite bed and the filtrate was washed with cold water (2x100 ml). The15 organic layer was dried over NazS04, and concentrated under reduced pressure to afford 2.3 gof the crude product which was taken as such for next reaction. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With nitrogen; potassium acetate; In phosphorus pentaoxide; 2-Methylpentane; ethyl acetate; | Dichlorobis(triphenylphosphine)palladium (TI) (0.172 g), tert-butyl 4-(3-bromophenyl)piperazine-1-carboxylate (3.59 g), bis(pinacolato)diboron (3.21 g) and potassium acetate (2.06 g) were combined in a flask which was then dried in a dessicator containing phosphorus pentoxide. The flask was then flushed with nitrogen and 1,4-dioxane (100 ml) was added. The resulting suspension was stirred at 80 C. for 20 hours. The mixture was allowed to cool and then the solvent was evaporated under reduced pressure. The residue was redissolved in ethyl acetate (100 ml) and washed with water (100 ml), then dried over magnesium sulfate, filtered through a silica pad and evaporated. The resultant product was purified by flash silica chromatography (elution solvent 25% ethyl acetate in isohexane). There was thus obtained tert-butyl 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine-1-carboxylate (3.34 g); Mass Spectrum: M+H=389; RT 3.23 min; NMR Spectrum: (DMSOd6) 7.32 (3H, m), 7.02 (1H, ddd), 3.57 (4H, t), 3.15 (4H, t), 1.48 (9H, s), 1.33 (12H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | [0198] To a microwave reaction tube was charged with 11 (70 mg, 0.15 mmol), 4-[3-(4,4,5,5- tetramethyl-[l,3,2]dioxaborolan-2-yl)-phenyl]-piperazine-l-carboxylic acid tert-butyl ester (70 mg, 0.18 mmol) and Pd(PPh3)4 (20 mg, 0.017 mmol). DMF (3 mL) was added to the above mixture followed by aqueous sodium carbonate (2 M; 0.3 mL, 0.6 mmol). The reaction tube was sealed and the suspension irradiated with microwave at 160 0C for 20 min. After cooling to room temperature, the mixture was filtered and the filtered solid washed with DCM. The filtrate was concentrated and the residue suspended in a mixture of DCM/TFA (5/3, 8 mL). The mixture was stirred at 60 0C for 1 h and then concentrated. The crude product was purified by HPLC, the corrected fractions combined and poured into saturated NaHCO3 solution (30 mL). The combined aqueous layers were extracted with EtOAc (2 x 30 mL) and the combined organic layers washed with brine, dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated and the residue re-dissolved in minimum amount of EtOAc and hexanes added until solid precipitated. After filtration, the title compound was obtained as a yellow solid (25 mg, 30% in 2 steps). 1H NMR (500 MHz, DMSO-d6): delta 1.60-1.70 (m, 4H), 2.42 (s, 3H), 2.48-2.55 (m, 4H), 2.78 (t, J = 5.9 Hz, 2H), 2.90 (t, J = 5.0 Hz, 4H), 3.16 (t, J = 5.0 Hz, 4H), 4.03 (t, J = 6.0 Hz, 2H), 6.90 (d, J = 9.1 Hz, 2H), 6.96 (dd, J = 8.3, 2.1 Hz, IH), 7.17 (d, J = 8.0 Hz, IH), 7.24 (s, IH), 7.30 (t, J = 8.0 Hz, IH), 7.62 (d, J = 4.0 Hz, IH), 7.71 (d, J = 9.0 Hz, 2H), 7.74 (d, J = 4.0 Hz, IH), 8.34 (s, IH), 9.31 (s, IH)MS (ES+): m/z 541 (M+H)+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;bis-triphenylphosphine-palladium(II) chloride; In 1,2-dimethoxyethane; ethanol; water; at 125℃; for 2h;Autoclave; Microwave irradiation; | Example A47. (l Rit..2S*)-5'-methoxy-2-(3-(3-(piperazin-l-vnphenyl)-l H-indazol-6- yl)spirorcvclopropane-l ,3'-indolinl-2'-one 2,2,2-trifluoroacetateS*, racemate A mixture of (R, 2S)- and (S, 2Lambda)-2-(3-Iodo-lH-indazol-6-yl)-5'- methoxyspiro[cyclopropane-l ,3'-indolin]-2'-one (50 mg, 0.12 mmol), tert-butyl 4-(3- (4,4,5, 5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenyl)piperazine-l-carboxylate (50 mg, 0.13 mmol), PdCl2(PPh3)2 (8 mg, 0.01 mmol) and 2M Na2CO3 (60 uL, 0.12 mmol) in DME/Eta2O/EtOEta (2.1 mL/0.6 mL/0.3 mL) was sealed and heated with stirring under microwave irradiation at 125 0C for 120 min. The crude reaction mixture was concentrated under reduced pressure to dryness, and purified by flash chromatography using hexanes/EtOAc as eluent (60:40 to 20:80) to give a pale yellow solid.The intermediate was dissolved in CH2Cl2 (3 mL) and TFA (30 uL) was added. The resulting mixture was stirred at rt for 4 h. The crude reaction mixture was concentrated under reduced pressure to dryness, and purified by preparative HPLC to give the title compound as a yellow powder and as the TFA salt (25 mg, 37%). 1H NMR (400 MHz, DMSOd6) delta 13.21 (s, I H), 10.45 (s, I H), 8.68 (br s, 1), 7.92 (d, J = 8.4 Jz. I H), 7.53-7.45 (m, 3H), 7.39 (t, J = 8.0 Hz, I H), 7.04-7.02 (m, 2H), 6.74 (d, J = 8.4 Hz, I H), 6.57 (dd, J = 8.4, 2.4 Hz, I H), 5.71 (d, J = 2.5 Hz, IH), 3.43-3.34 (m, I H), 3.29 (s, 3H), 3.29-3.24 (m, 3H), 3.23-3.16 (m 2H), 2.36-2.32 (m, I H), 2.02-1.98 (m, I H); MS ESI 466.3 [M + H]+, calcd for [C28H27N5O2 + H]+ 466.22. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With caesium carbonate;(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In 1,2-dimethoxyethane; water; at 110℃; for 7h;Inert atmosphere; Sealed tube; | Compound 116 is prepared in the same manner as compound 114 starting with 3-bromo-6-(pyrid-3-yl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 6 (600 mg, 1.85 mmol) and <strong>[540752-87-2]tert-butyl 4-[3-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl]piperazine-1-carboxylate</strong> (930 mg, 2.39 mmol) to give 116 in the form of a brown solid (824 mg, 80%).MS: m/z=507 (ES+).1H NMR (300 MHz, DMSO-d6) delta ppm 12.37 (s, 1H), 9.38 (s, 1H), 9.05 (s, 1H), 9.04 (s, 1H), 8.98 (s, 1H), 8.95 (s, 1H), 8.60 (d, 1H), 8.52 (d, 1H), 7.55 (dd, 1H), 7.40 (t, 1H), 7.37 (s, 1H), 7.26 (d, 1H), 7.02 (d, 1H), 3.51 (t, 4H), 3.25 (t, 4H), 1.44 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83.2% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate; In 1,4-dioxane; at 110℃; for 5h; | To a solution of 42c (0.94 g, 2.75 mmol) in dioxane (30 mL) was added 4,4,4?,4?,5,5,5?,5?-octamethyl-2,2?-bi(1,3,2-dioxaborolane) (1.40 g, 5.51 mmol), KOAc (811 mg, 8.26 mmol), Pd(dppf)Cl2 (0.27 mmol), and dioxane (15 mL). The reaction system was purged and stirred at 110 C. for 5 h. The reaction mixture was cooled to 25 C. and poured into water (15 mL), extracted with EtOAc (20 mL×3). The organic layer was dried over Na2SO4, concentrated, and by purified by column (PE:EtOAc=15:1-10:1) to give tert-butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate 42d (0.89 g, yield: 83.2%). LCMS: (5-95, AB, 1.5 min), 1.015 min, MS=388.8 [M+1]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
A mixture of 1 ,1 -dimethylethyl 4-(3-bromo-4-[(3-chlorophenyl)sulfonyl]amino}-6- methylthieno[2,3-6]pyridin-2-yl)-1 /-/-pyrazole-1 -carboxylate (Description 75) (100 mg, 0.171 mmol), 3-(4-ferf-butoxycarbonylpiperazinyl)phenylboronic acid, pinacol ester (133 mg, 0.343 mmol), potassium carbonate (71.0 mg, 0.514 mmol),tetrakis(triphenylphosphine)palladium(0) (19.79 mg, 0.017 mmol) andbis(triphenylphosphine)palladium(ll) chloride (12.02 mg, 0.017 mmol) were weighed into a microwave vial. 1 ,4-Dioxane (2 mL), DMF (1 mL) and water (0.5 mL) were added and the mixture heated in a microwave at 120C for 15 min. At this point, all three mixtures were combined and concentrated. The residue was then passed through an SCX cartridge, eluting with MeOH (150 mL) and then 2M NH3 in MeOH (200 mL). The basic methanolic solution was concentrated and purified by normal phase chromatography, eluting with 0-100% ethyl acetate in DCM to give a residue (168 mg), which was subsequently taken-up in DCM (5 mL) and TFA (1 mL) added. The reaction mixture was stirred at RT for ca. 1 h and was then passed through an SCX cartridge, eluting with MeOH (100 mL) and then with 2M NH3 in MeOH (150 mL). The basic methanolic solution was concentrated and purified by normal phase chromatography, eluting with 0-20% 2M NH3 in MeOH in DCM to give a solid (ca. 125 mg). The solid was suspended in DCM (5 mL) and HCI (2M in diethyl ether) (0.128 mL, 0.257 mmol) was added. The mixture was stirred at RT for 30 min and solvent was then removed. The solid was triturated with DCM (5 mL x 3) and then dried in vacuum oven, to give the title compound (102 mg) as hydrochloride salt. LCMS (A) m/z: 565 [M+1 ]+, Rt 0.95 min (acidic). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 120℃; for 0.5h;microwave irradiation; Inert atmosphere; | Under nitrogen, 3-bromo-2,6-dimethylthieno[2,3-6]pyridin-4-amine (130 mg, 0.506 mmol) (Description 8) was dissolved in 1 ,4-dioxane (3 mL) and water (1 mL) and 1 ,1 - dimethylethyl 4-[3-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)phenyl]-1- piperazinecarboxylate (294 mg, 0.758 mmol), tetrakis(triphenylphosphine)palladium(0) (58.4 mg, 0.051 mmol) and potassium carbonate (210 mg, 1.517 mmol) were added. The mixture was then heated in a microwave at 120C for 30 min. Ethyl acetate (10 mL) was added and the mixture washed with water (2 x 5 mL). The organic layer was dried over MgS04, filtered and solvent removed in vacuo. Purification by chromatography on silica gel, eluting with a gradient of 0-70% ethyl acetate in cyclohexane, afforded the title compound (197 mg). LCMS (A) m/z: 439 [M+1]+, Rt 0.99 min (acidic). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; caesium carbonate; In ethanol; toluene; at 20 - 110℃; for 1.16667h;Microwave irradiation; | General procedure: Method J: To the mixture of 5 mol% of S-Phos, 5 mol% of Pd(OAc)2, compound 15 (1 equivalent), 2-fluoro- phenylboronic acid (1.5 equivalents) and Cs2CO3 (3 equivalents) a mixture of toluene/ethanol (1:1) was added and stirred at room temperature for 10 mm, and then irradiated at 110 C for 1 h, using the microwave reactor. After irradiation, the sample was cooled and the solvent was evaporated to dryness.The resulting residue was extracted with EtOAc; the organic layer was washed with brine and dried over Na2SO4 and the solvent evaporated to dryness to afford crude 16a. Purified material was obtained by silica gel column chromatography using EtOAc/Petrol ether as the eluent. Compound 24b (302 mg, 53%) was obtained by coupling 23 (400 mg, 0.92 mmol) with {3-[4-(tert- butoxycarbonyl)piperazin-1-yl]phenyl} boronic ester (439.3 mg, 1.13 mmol) using S-Phos (15.0 mg,0.036 mmol), Pd(OAc)2 (4.1 mg, 0.018 mmol) and Cs2CO3 (601 mg, 1.84 mmol) using the general procedure described above for 16a-g. This material was used directly for the next step. LC-ESMS m/z 606.08[M+1] HPLC; 95.7%; Yield= 53%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89.7% | Using similar reaction conditions as described in step-ii of example-1, 5-bromo-3-(l-(2,5-difluorobenzyl)-IH-pyrazol-4-yl)-l-tosyl-1H-pyrrolo[2,3-b ]pyridine (step-i of example-4)(380mg, 0.552mmol) was coupled with tert-butyl 4-(3-( 4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)phenyl) piperazine-1-carboxylate (intermediate 37) ( 428mg, 1.104mmol)in sodium carbonate (176mg, 1.657mmol), Pd(PPh3)zCh (38.7mg, 0.0552mmol),25 toluene/ethanol/water (30/15/6 ml). This afforded 454mg (89.7% yield) after purification bycolumn (Silica gel60/120) using 35%ethyl acetate in hexane as eluent.MS: m/z = 725.6 (M+2) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48.6% | Using similar reaction conditions as described in step-ii of example-1, 5-bromo-3-(1-(3-5 fluorobenzyl)-1H-pyrazol-4-yl)-l-tosyl-1H-pyrrolo[2,3-b ]pyridine (compound of step-i ofexample-9) (225 mg, 0.428mmol) was coupled with tert-butyl 4-(3-(4,4,5,5-tetramethyl-1 ,3 ,2-dioxaborolan-2-yl) phenyl) piperazine-1-carboxylate (intermediate 3 7) (332mg,0.857mmol) in sodium carbonate (182mg, 1.714mmol), Pd(PPh3)zCh (34mg, 0.0285mmol),toluene/ethanol/water (22/11/5.5 ml). This afforded 147mg (48.6% yield) after purification10 by column (Silica gel 601120) using 35%ethyl acetate in hexane as eluent.MS: m/z = 706.8 (M+ 1) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate; In water; acetonitrile; at 120 - 150℃; for 3.16667h;Microwave irradiation; | To 3-bromo-5-nitro- lH-pyrazolo[3,4-b]pyridine 111 (0.1 g, 0.41 mmol) in acetonitrile (3 ml) were added tert-butyl 4-[3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2- yl)phenyl]piperazine- 1 -carboxylate 112 (0.2 g, 0.52 mmol), [1,1 '- bis(diphenylphosphino)ferrocene]dichloropalladium(ii) (12 mg, 0.016 mmol), and aqueous potassium carbonate (1 ml, 1 M). The reaction mixture was irradiated in microwave at 120 C for 20 minutes and at 150C for 170 minutes. The reaction mixture was poured into water and extracted with ethyl acetate. The organic layer was washed by brine and dried under sodium sulfate. After removal of drying agent and solvent, the residue was purified by silica gel column chromatography to provide compound 113 as a brownish solid (58 mg, 23%). MS(ESI) [M-H-]- = 423.20. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; water; at 90℃; for 8h; | General procedure: To a solution of 5 ( 1.0 equiv), [(N-Boc)piperazin- 1 -y I jpheiw boronic acid pinacoi ester ( 1.1 equiv) and Pd(PPhs j (0.12 equiv) in DME, (iM) aqueous Na2C( (2.0 equiv) was added. The reaction mixture was stirred under argon atmosphere at 90 C for 8 h. The reaction mixture was filtered and concentrated. The residue was purified by flash column chromatography, eiuting with a mixture cyclohexane EtOAc to give 6 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43.2% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate; In 1,4-dioxane; water; at 120℃; for 0.833333h;Inert atmosphere; Microwave irradiation; | To a solution of 42d (400 mg, 1.03 mmol) in dioxane-H2O (5 mL) was added tert-butyl (3,5-dibromo-4-ethylpyridin-2-yl)carbamate 42e (391 mg, 1.0 mmol), K2CO3 (427 mg, 3.09 mmol) and Pd(dppf)Cl2 (45 mg). The reaction mixture was purged with N2 and heated with microwave irradiation at 120 C. for 50 min. The reaction mixture was cooled to 25 C. then poured to water (15 mL). It was extracted with EtOAc (3×20 mL) and the organic layer was dried over Na2SO4, concentrated it and purified by column (PE:EtOAc=20:1-5:1) to give tert-butyl 4-(3-(5-bromo-6-((tert-butoxycarbonyl)amino)-4-ethylpyridin-3-yl)phenyl)piperazine-1-carboxylate 42f (250 mg, yield: 43.2%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In tetrahydrofuran; water; at 60℃; for 24h;Inert atmosphere; | The mixture of 2,4-dichloropyrimidine (500 mg, 3.36 mmol), <strong>[540752-87-2]tert-butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate</strong> (1.24 g), tetrakis(triphenylphosphine)palladium(0) (739 mg), sodium carbonate (508 mg), THF (20 mL) and water (2.00 mL) was stirred at 60 C. under nitrogen atmosphere for 24 hr. The mixture was quenched with water at room temperature and extracted with ethyl acetate. The organic layer was separated, washed with water and saturated brine, dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by column chromatography (ethyl acetate/hexane) to give the title compound. MS m/z 375.1 [M+1]+. | |
With tetrakis(triphenylphosphine)palladium (0); | A) tert-butyl 4-(3-(2-chloropyrimidin-4-yl)phenyl)piperazine-1-carboxylate A mixture of 2,4-dichloropyrimidine (500 mg), <strong>[540752-87-2]tert-butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate</strong> (1.24 g), tetrakis(triphenylphosphine)palladium(0) (739 mg), sodium carbonate (508 mg), THF (20 mL) and water (2.0 mL) was stirred at 60 C. under nitrogen atmosphere for 24 hr. The mixture was quenched with water at room temperature and extracted with ethyl acetate. The organic layer was separated, washed with water and saturated brine, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by column chromatography (ethyl acetate/hexane) to give the title compound. MS m/z 375.1 [M+1]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; caesium carbonate; In water; toluene; at 80℃; for 12h;Inert atmosphere; | General procedure: 5-bromo-3-(1-(2-chloro-5-fluorophenyl)ethoxy)pyridin-2-amine(3.735 g, 10.8 mmol), cesium carbonate (12.382 g, 38.0 mmol) and tert-butyl4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylatewas(4.915g,13.0 mmol) was dissolved in Toluene (15 mL) and water (2 mL). The reactionsolution was purged with N2 for 20 minutes, then PdCl2(dppf)2(0.794mg, 1.1 mmol) was added and the mixture was purged with N2 for 10minutes. The resulting mixture was stirred for 12 h at 80 oC under N2.After cooling down the mixture toroom temperature, the solution wasconcentrated with a rotary evaporator. The crude productwas purified by silica gel chromatography (dichloromethane/methanol = 100: 1,v/v) to obtain the product as a yellow oil (4.761 g, 85 %). |
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.99
[ 330793-01-6 ]
tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Similarity: 0.91
[ 893441-86-6 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.83
[ 1161362-35-1 ]
tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate
Similarity: 0.81
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.99
[ 330793-01-6 ]
tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Similarity: 0.91
[ 1912446-60-6 ]
tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinoline-1(2H)-carboxylate
Similarity: 0.85
[ 262444-42-8 ]
tert-Butyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
Similarity: 0.79
[ 330794-35-9 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate
Similarity: 0.78
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.99
[ 330793-01-6 ]
tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Similarity: 0.91
[ 893441-86-6 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.83
[ 1161362-35-1 ]
tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate
Similarity: 0.81
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.99
[ 656257-45-3 ]
4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester
Similarity: 0.77
[ 496786-98-2 ]
tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate
Similarity: 0.71
[ 1150114-76-3 ]
(4-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)phenyl)boronic acid
Similarity: 0.65